BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28263689)

  • 1. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.
    Zhao Y; Xiong P; McCullough LE; Miller EE; Li H; Huang Y; Zhao M; Wang MJ; Kang M; Wang Q; Li JY
    J Womens Health (Larchmt); 2017 Mar; 26(3):294-302. PubMed ID: 28263689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accuracy and direct medical cost of different screening modalities for breast cancer among Chinese women].
    Kang M; Zhao Y; Huang Y; Li J; Liu L; Li H
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):236-40. PubMed ID: 24785288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
    Acikgoz A; Ergor G
    Asian Pac J Cancer Prev; 2013; 14(3):1737-42. PubMed ID: 23679266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices.
    Albeshan SM; Hossain SZ; Mackey MG; Peat JK; Al Tahan FM; Brennan PC
    Clin Imaging; 2019; 54():138-147. PubMed ID: 30639525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening MRI in Women With a Personal History of Breast Cancer.
    Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
    Tice JA; Cummings SR; Ziv E; Kerlikowske K
    Breast Cancer Res Treat; 2005 Nov; 94(2):115-22. PubMed ID: 16261410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of early diagnostic tools for breast cancer].
    Shen SJ; Sun Q; Xu YL; Zhou YD; Guan JH; Mao F; Lin Y; Wang XJ; Han SM
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):877-80. PubMed ID: 23291142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.
    Domingo L; Hofvind S; Hubbard RA; Román M; Benkeser D; Sala M; Castells X
    Eur Radiol; 2016 Aug; 26(8):2520-8. PubMed ID: 26560729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer.
    Huang Y; Wang H; Lyu Z; Dai H; Liu P; Zhu Y; Song F; Chen K
    Cancer Biol Med; 2021 Sep; 19(9):1375-84. PubMed ID: 34570443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Møller MH; Lousdal ML; Kristiansen IS; Støvring H
    Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening practices among Hong Kong Chinese women.
    Kwok C; Fong DY
    Cancer Nurs; 2014; 37(1):59-65. PubMed ID: 23357890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.
    Taif S; Tufail F; Alnuaimi AS
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e250-8. PubMed ID: 24673798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study.
    Hassan N; Ho WK; Mariapun S; Teo SH
    BMC Public Health; 2015 Jun; 15():548. PubMed ID: 26065413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.